Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 35, Issue 3, 2016, Pages 617-622

  Yilmaz Oner, Sibel ^a   Oner, Can ^b   Dogukan, Fatih Mert ^a   Moses, Toklong Filam ^a   Demir, Kubra ^a   Tekayev, Nazar ^a   Atagunduz, Pamir ^a   Tuglular, Serhan ^a   Direskeneli, Haner ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

Author keywords

LupusQoL TR; Quality of life; SF 36; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG MEGADOSE; FEMALE; GROUPS BY AGE; HUMAN; LOW DRUG DOSE; LUPUS QUALITY OF LIFE QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SHORT FORM 36; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TURKISH CITIZEN; HEALTH STATUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TURKEY;

ADULT; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TURKEY;

EID: 84960339272     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-2930-1     Document Type: Article

References (32)

1. Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23(11):1953–5
2. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P (2000) Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in RheumatologyOutcome Measures in Rheumatology. Lupus 9(5):322–7, Review
3. Ware JE, Kosinski M, Keller SD (1994) SF-36 physical and mental health summary scales: a user’s manual. The Health Institute, New England Medical Center, Boston
4. Jolly M (2005) How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 32(9):1706–8
5. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A (1996) A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5(3):190–5
6. Kuriya B, Gladman DD, Ibañez D, Urowitz MB (2008) Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 59(2):181–5. doi:10.1002/art.23339
7. Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, Senécal JL, Penrod JR, Joseph L, St Pierre Y, Pineau C, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE, Tri-Nation Study Group (2007) The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum 57(1):64–70
8. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, Peers K, Isenberg D, Ferenkeh-Koroma A, Griffiths B, Akil M, Maddison P, Teh LS (2007) Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 57(6):972–9
9. Curry SL, Levine SB, Corty E, Jones PK, Kurit DM (1994) The impact of systemic lupus erythematosus on women's sexual functioning. J Rheumatol 12:2254–60.10
10. Grootscholten C, Ligtenberg G, Derksen RH, Schreurs KM, de Glas-Vos JW, Hagen EC, van den Wall Bake AW, Huizinga TW, van den Hoogen FH, Bijl M, van Houwelingen JC, Snoek FJ, Berden JH (2003) Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 12(6):635–44
11. Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, Cheng YK, Chng HH, Badsha H, Law WG, Lau TC, Chew LC, Ho HJ, Pong LY, Hoi LS, Sangeetha N, Chan SP, Howe HS (2005) Development and preliminary validation of a systemic lupus erythematosus specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 44(10):1267–76
12. Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (2009) The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 68(2):196–200
13. Touma Z, Gladman DD, Ibañez D, Urowitz MB (2011) Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? J Rheumatol 38(9):1898–905
14. García-Carrasco M, Mendoza-Pinto C, Cardiel MH, Méndez-Martínez S, García-Villaseñor A, Jiménez-Hernández C, Alonso-García NE, Briones-Rojas R, Ramos-Álvarez G, López-Colombo A (2012) Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL©. Lupus 21(11):1219–24. doi:10.1177/0961203312456749
15. McElhone K, Castelino M, Abbott J, Bruce IN, Ahmad Y, Shelmerdine J, Peers K, Isenberg D, Ferenkeh-Koroma A, Griffiths B, Akil M, Maddison P, Gordon C, Teh LS (2010) The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol 37(11):2273–9
16. Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, Maurier F, Kaminsky P, Pennaforte JL, Magy-Bertrand N, Arnaud L, Binquet C, Guillemin F, Bonithon-Kopp C. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE. Rheumatology (Oxford). 2014 Oct 30. pii: keu410. [Epub ahead of print]
17. Kaya A, Goker B, Cura ES, Tezcan ME, Tufan A, Mercan R, Bitik B, Haznedaroglu S, Ozturk MA, Mikolaitis-Preuss RA, Block JA, Jolly M. Turkish lupusPRO: cross-cultural validation study for lupus.
18. Pamuk ON, Onat AM, Donmez S, Mengüs C, Kisacik B (2014) Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients. Lupus 33(8):1079–84. doi:10.1007/s10067-013-2345-9. Epub 2013 Aug 11.18
19. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
20. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–40
21. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66
22. Schmeding A, Schneider M (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27(3):363–75. doi:10.1016/j.berh.2013.07.009, Review
23. Gordon C, Isenberg D, Lerstrøm K, Norton Y, Nikaï E, Pushparajah DS, Schneider M (2013) The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey. Rheumatology (Oxford) 52(12):2292–301. doi:10.1093/rheumatology/ket300
24. Doria A, Rinaldi S, Ermani M, Salaffi F, Iaccarino L, Ghirardello A, Zampieri S, Della Libera S, Perini G, Todesco S (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology (Oxford) 43(12):1580–6
25. Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vilá LM, Reveille JD (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 51(3):465–74
26. Thumboo J, Fong KY, Chan SP, Leong KH, Feng PH, Thio ST, Boey ML (2000) A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 27(6):1414–20
27. Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D (1998) Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7(2):101–7
28. Strand V, Aranow C, Cardiel MH, Alarcón-Segovia D, Furie R, Sherrer Y, Tumlin J, Wallace DJ, Crawford B (2003) LJP 394 Investigator Consortium. Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus 12(9):677–86
29. Strand V, Crawford B (2005) Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoeco Outcomes Res 5(3):317–26. doi:10.1586/14737167.5.3.317
30. Shen B, Feng G, Tang W, Huang X, Yan H, He Y, Chen W, Da Z, Liu H, Gu Z (2014) The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis. Clin Exp Rheumatol 32(1):101–7
31. Gladman DD, Urowitz MB, Gough J, MacKinnon A (1997) Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 24(11):2145–8
32. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, Fogg L, Block J (2010) Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis 69(1):29–33. doi:10.1136/ard.2008.094763. Epub